Therefore, although there remains a possibility that H2B increases pneumonia risk in acute stroke patients to an extent similar to that observed in critical care [10, 11], our study indicates that H2B use is unlikely to increase pneumonia risk strongly in acute stroke patients. Here, H2BC21 is linked to susceptibility to pneumonia measurement.